Early research (Phase 1)Study completedNCT02439359
What this trial is testing
A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects
Who this might be right for
Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)
ContraFect 20